跳转至内容
Merck

SML2146

Sigma-Aldrich

马来酸盐 SR-18292

≥98% (HPLC)

别名:

马来酸盐 SR-18292, 1-[(1,1-二甲基乙基)[(4-甲基苯基)甲基]氨基] -3-(1H-吲哚-4-基氧基)-2-丙醇马来酸酯, SR 18292, SR 18292马来酸酯

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C23H30N2O2 · C4H4O4
分子量:
482.57
分類程式碼代碼:
12352200
NACRES:
NA.77

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: 2 mg/mL, clear

儲存溫度

2-8°C

SMILES 字串

CC(C)(C)N(CC(O)COC1=CC=CC2=C1C=CN2)CC3=CC=C(C)C=C3.O=C(O)/C=C\C(O)=O

應用

SR-18292马来酸盐已作为过氧化物酶体增殖物激活受体γ共激活因子1α (PGC1α) 的抑制剂,用于研究吡格列酮对脱髓鞘轴突的保护作用。

生化/生理作用

SR-18292是一种可通过PGC-1α乙酰化作用的增强以及糖原异生基因表达的抑制而成为一种有效的特异性肝糖异生抑制剂。SR-18292可在T2D小鼠模型中降低血糖并提高肝胰岛素敏感性。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Simon Licht-Mayer et al.
Acta neuropathologica, 140(2), 143-167 (2020-06-24)
Axonal loss is the key pathological substrate of neurological disability in demyelinating disorders, including multiple sclerosis (MS). However, the consequences of demyelination on neuronal and axonal biology are poorly understood. The abundance of mitochondria in demyelinated axons in MS raises
Rama Krishna Nimmakayala et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 27(19), 5415-5429 (2021-06-27)
Metabolic reprogramming and cancer stem cells drive the aggressiveness of pancreatic ductal adenocarcinoma (PDAC). However, the metabolic and stemness programs of pancreatic precursor lesions (PPL), considered early PDAC development events, have not been thoroughly explored. Meta-analyses using gene expression profile
Kfir Sharabi et al.
Cell, 169(1), 148-160 (2017-03-25)
Type 2 diabetes (T2D) is a worldwide epidemic with a medical need for additional targeted therapies. Suppression of hepatic glucose production (HGP) effectively ameliorates diabetes and can be exploited for its treatment. We hypothesized that targeting PGC-1α acetylation in the liver
Prakash P Praharaj et al.
Autophagy, 20(6), 1359-1382 (2024-03-07)
Mitophagy involves the selective elimination of defective mitochondria during chemotherapeutic stress to maintain mitochondrial homeostasis and sustain cancer growth. Here, we showed that CLU (clusterin) is localized to mitochondria to induce mitophagy controlling mitochondrial damage in oral cancer cells. Moreover

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门